Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
XBiotech ( (XBIT) ) has issued an announcement.
XBiotech Inc. has announced the appointment of Dr. Thomas Kündig and Craig Rademaker to its Board of Directors as of June 24, 2025. Dr. Kündig, a leader in academic medicine with significant contributions to immunodermatology, will join the Compensation Committee, while Mr. Rademaker, with extensive experience in the financial industry, will join the Audit Committee. These appointments are expected to enhance the company’s strategic direction and governance, potentially impacting its operations and industry positioning positively.
More about XBiotech
Average Trading Volume: 55,333
Technical Sentiment Signal: Sell
Current Market Cap: $76.22M
See more data about XBIT stock on TipRanks’ Stock Analysis page.